ISCOMATRIX™ adjuvant reduces mucosal tolerance for effective pulmonary vaccination against influenza

References

• Brandtzaeg P. Induction of secretory immunity and memory at mucosal surfaces. Vaccine 2007; 25:5467-84; PMID:17227687; http://dx.doi.org/10.1016/j.vaccine.2006.12.001
   PubMed Web of Science ®Google Scholar
• Ogra PL, Faden H, Welliver RC. Vaccination strategies for mucosal immune responses. Clin Microbiol Rev 2001; 14:430-+; PMID:11292646; http://dx.doi.org/10.1128/CMR.14.2.430-445.2001
   PubMedGoogle Scholar
• Hu W, Pasare C. Location, location, location: tissue-specific regulation of immune responses. J Leukocyte Biol 2013; 94:409-21; PMID:23825388; http://dx.doi.org/10.1189/jlb.0413207
   PubMed Web of Science ®Google Scholar
• Curotto de Lafaille MA, Lafaille JJ, Graca L. Mechanisms of tolerance and allergic sensitization in the airways and the lungs. Curr Opin Immunol 2010; 22:616-22; PMID:20884192; http://dx.doi.org/10.1016/j.coi.2010.08.014
   PubMedGoogle Scholar
• Chen K, Cerutti A. Vaccination strategies to promote mucosal antibody responses. Immunity 2010; 33:479-91; PMID:21029959; http://dx.doi.org/10.1016/j.immuni.2010.09.013
   PubMed Web of Science ®Google Scholar
• Mestecky J, Russell MW, Elson CO. Perspectives on mucosal vaccines: is mucosal tolerance a barrier? J Immunol 2007; 179:5633-8; PMID:17947632; http://dx.doi.org/10.4049/jimmunol.179.9.5633
   PubMed Web of Science ®Google Scholar
• Vujanic A, Wee JLK, Snibson KJ, Edwards S, Pearse M, Quinn C, Moloney M, Taylor S, Scheerlinck JP, Sutton P. Combined mucosal and systemic immunity following pulmonary delivery of ISCOMATRIXTM adjuvanted recombinant antigens. Vaccine 2010; 28:2593-7; PMID:20096391; http://dx.doi.org/10.1016/j.vaccine.2010.01.018
   PubMed Web of Science ®Google Scholar
• Nardelli-Haefliger D, Lurati F, Wirthner D, Spertini F, Schiller JT, Lowy DR, Ponci F, De Grandi P. Immune responses induced by lower airway mucosal immunisation with a human papillomavirus type 16 virus-like particle vaccine. Vaccine 2005; 23:3634-41; PMID:15882523; http://dx.doi.org/10.1016/j.vaccine.2005.02.019
   PubMed Web of Science ®Google Scholar
• Amorij JP, Saluja V, Petersen AH, Hinrichs WLJ, Huckriede A, Frijlink HW. Pulmonary delivery of an inulin-stabilized influenza subunit vaccine prepared by spray-freeze drying induces systemic, mucosal humoral as well as cell-mediated immune responses in BALB/c mice. Vaccine 2007; 25:8707-17; PMID:17996993; http://dx.doi.org/10.1016/j.vaccine.2007.10.035
   PubMed Web of Science ®Google Scholar
• Wee JL, Scheerlinck JP, Snibson KJ, Edwards S, Pearse M, Quinn C, Sutton P. Pulmonary delivery of ISCOMATRIX influenza vaccine induces both systemic and mucosal immunity with antigen dose sparing. Mucosal Immunol 2008; 1:489-96; PMID:19079216; http://dx.doi.org/10.1038/mi.2008.59
   PubMed Web of Science ®Google Scholar
• Scheerlinck JP, Snibson KJ, Bowles VM, Sutton P. Biomedical applications of sheep models: from asthma to vaccines. Trends Biotechnol 2008; 26:259-66; PMID:18353472; http://dx.doi.org/10.1016/j.tibtech.2008.02.002
   PubMed Web of Science ®Google Scholar
• Vujanic A, Snibson KJ, Wee JL, Edwards SJ, Pearse MJ, Scheerlinck JP, Sutton P. Long-term antibody and immune memory response induced by pulmonary delivery of the influenza Iscomatrix vaccine. Clin Vaccine Immunol: CVI 2012; 19:79-83; PMID:22072721; http://dx.doi.org/10.1128/CVI.05265-11
   PubMedGoogle Scholar
• Vujanic A, Wee JL, Snibson KJ, Edwards S, Pearse M, Quinn C, Moloney M, Taylor S, Scheerlinck JP, Sutton P. Combined mucosal and systemic immunity following pulmonary delivery of ISCOMATRIX adjuvanted recombinant antigens. Vaccine 2010; 28:2593-7; PMID:20096391; http://dx.doi.org/10.1016/j.vaccine.2010.01.018
   PubMed Web of Science ®Google Scholar
• Soroosh P, Doherty TA, Duan W, Mehta AK, Choi H, Adams YF, Mikulski Z, Khorram N, Rosenthal P, Broide DH, et al. Lung-resident tissue macrophages generate Foxp3+ regulatory T cells and promote airway tolerance. J Exp Med 2013; 210:775-88; PMID:23547101; http://dx.doi.org/10.1084/jem.20121849
   PubMed Web of Science ®Google Scholar
• Hussell T, Bell TJ. Alveolar macrophages: plasticity in a tissue-specific context. Nat Rev Immunol 2014; 14:81-93; PMID:24445666; http://dx.doi.org/10.1038/nri3600
   PubMed Web of Science ®Google Scholar
• Thorburn AN, Foster PS, Gibson PG, Hansbro PM. Components of Streptococcus pneumoniae suppress allergic airways disease and NKT cells by inducing regulatory T cells. J Immunol 2012; 188:4611-20; PMID:22461699; http://dx.doi.org/10.4049/jimmunol.1101299
   PubMed Web of Science ®Google Scholar
• Lloyd CM, Murdoch JR. Tolerizing allergic responses in the lung. Mucosal Immunol 2010; 3:334-44; PMID:20505664; http://dx.doi.org/10.1038/mi.2010.19
   PubMedGoogle Scholar
• Preston JA, Thorburn AN, Starkey MR, Beckett EL, Horvat JC, Wade MA, O'Sullivan BJ, Thomas R, Beagley KW, Gibson PG, et al. Streptococcus pneumoniae infection suppresses allergic airways disease by inducing regulatory T-cells. Eur Respiratory J 2011; 37:53-64; PMID:20525707; http://dx.doi.org/10.1183/09031936.00049510
   PubMed Web of Science ®Google Scholar
• Wikstrom ME, Batanero E, Smith M, Thomas JA, von Garnier C, Holt PG, Stumbles PA. Influence of mucosal adjuvants on antigen passage and CD4(+) T cell activation during the primary response to airborne allergen. J Immunol 2006; 177:913-24; PMID:16818746; http://dx.doi.org/10.4049/jimmunol.177.2.913
   PubMed Web of Science ®Google Scholar
• Morelli AB, Becher D, Koernig S, Silva A, Drane D, Maraskovsky E. ISCOMATRIX: a novel adjuvant for use in prophylactic and therapeutic vaccines against infectious diseases. J Med Microbiol 2012; 61:935-43; PMID:22442293; http://dx.doi.org/10.1099/jmm.0.040857-0
   PubMed Web of Science ®Google Scholar
• Drane D, Pearse M. The ISCOMATRIX adjuvant In Schijns VE, O‘Hagan DT, eds. Immunopotentiators in Modern Vaccines. Amsterdam: Boston Elsevier Academic Press, 2006.
   Google Scholar